Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

被引:479
|
作者
Yuen, Man-Fung [1 ]
Tanaka, Yasuhito [2 ]
Fong, Daniel Yee-Tak [3 ]
Fung, James [1 ]
Wong, Danny Ka-Ho [1 ]
Yuen, John Chi-Hang [1 ]
But, David Ylu-Kuen [1 ]
Chan, Annie On-On [1 ]
Wong, Benjamin Chun-Yu [1 ]
Mjzokami, Masashi [2 ]
Lai, Ching-Lung [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi, Japan
[3] Univ Hong Kong, Queen Mary Hosp, Dept Nursing Studies, Hong Kong, Hong Kong, Peoples R China
关键词
Chronic hepatitis B; Hepatocellular carcinoma; Risk factor; Prediction; BASAL CORE PROMOTER; VIRUS GENOTYPE-B; E-ANTIGEN; PRECORE MUTATIONS; LIVER-DISEASE; VIRAL LOAD; DNA LEVELS; HONG-KONG; INFECTION; CARRIERS;
D O I
10.1016/j.jhep.2008.07.023
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: To determine whether gender, age, hepatitis B virus genotype, core promoter and precore mutations, HBeAg/anti-HBe status, HBV DNA, ALT levels and cirrhosis on presentation were independent risk factors and derive a novel risk score for the development of HCC. Methods: CHB patients (820) were followed up (mean duration 76.8 months) for the occurrence of HCC. Results: The 5- and 10-year prevalence of HCC were 4.4% and 6.3%, respectively. Cox regression analysis showed that male gender (p = 0.025, RR 2.98), increasing age (p < 0.001, RR 1.07), higher HBV DNA levels (p = 0.02, RR 1.28), core promoter mutations (p = 0.007, RR 3.66), and presence of cirrhosis (p < 0.001, RR 7.31) were independent risks for the development of HCC. A risk score was derived and validated with sensitivity > 84% and specificity > 76% to predict the 5- and 10-year risks for the development of HCC. The AUC for the 5- and 10-year prediction were 0.88 and 0.89, respectively. Conclusions:The risk score, based on age, gender, HBV DNA levels, core promoter mutations and cirrhosis, can estimate the chance of development of HCC in 5 and 10 years after presentation. It can be used to identify high-risk CHB patients for treatment and screening of HCC. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:80 / 88
页数:9
相关论文
共 50 条
  • [1] Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    Yuen, M. F.
    Tanaka, Y.
    Fong, D. Y.
    Fung, J.
    Wong, D. K.
    Yuen, J. C.
    But, D. Y.
    Chan, A. O.
    Wong, B. C.
    Mizokami, M.
    Lai, C. L.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S252 - S252
  • [2] Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
    Yang, Hwai-I
    Yuen, Man-Fung
    Chan, Henry Lik-Yuen
    Han, Kwang-Hyub
    Chen, Pei-Jer
    Kim, Do-Young
    Ahn, Sang-Hoon
    Chen, Chien-Jen
    Wong, Vincent Wai-Sun
    Seto, Wai-Kay
    [J]. LANCET ONCOLOGY, 2011, 12 (06): : 568 - 574
  • [3] Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B
    Pastras, Ploutarchos
    Zazas, Evaggelos
    Kalafateli, Maria
    Aggeletopoulou, Ioanna
    Tsounis, Efthymios P.
    Kanaloupitis, Stavros
    Zisimopoulos, Konstantinos
    Kottaridou, Eirini-Eleni-Konstantina
    Antonopoulou, Aspasia
    Drakopoulos, Dimosthenis
    Diamantopoulou, Georgia
    Tsintoni, Aggeliki
    Thomopoulos, Konstantinos
    Triantos, Christos
    [J]. CANCERS, 2024, 16 (14)
  • [4] Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B
    Seo, Seung In
    Kim, Hyoung Su
    Yang, Bo Kyung
    Kang, Jin Gu
    Shin, Woon Geon
    Lee, Jin Heon
    Kim, Hak Yang
    Jang, Myoung Kuk
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (05) : 711 - 717
  • [5] Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma
    Hung, Ivan Fan-Ngai
    Wong, Danny Ka-Ho
    Poon, Ronnie Tung-Ping
    Fong, Daniel Yee-Tak
    Chui, Ada Hang-Wai
    Seto, Wai-Kay
    Fung, James Yan-Yue
    Chan, Albert Chi-Yan
    Yuen, John Chi-Hang
    Tiu, Randal
    Choi, Olivia
    Lai, Ching-Lung
    Yuen, Man-Fung
    [J]. PLOS ONE, 2016, 11 (02):
  • [6] INDEPENDENT RISK FACTORS AND PREDICTIVE SCORE FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C AFTER SUSTAINED RESPONSE TO PEGINTERFERON AND RIBAVIRIN COMBINATION THERAPY
    Chang, K-C
    Lee, C-M
    Lu, S-N
    Wang, J-H
    Hung, C-H
    Chen, C-H
    Hu, T-H
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S432 - S432
  • [7] Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C
    Carlos Gavilan, Juan
    Ojeda, Guillermo
    Arnedo, Rocio
    Puerta, Susana
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (08) : 846 - 851
  • [8] Development and Validation of a Risk Score for Hepatocellular Carcinoma in Chronic Hepatitis B Patients under Antiviral Treatment
    Hsu, Yao-Chun
    Yip, Terry Cheuk-Fung
    Ho, Hsiu-Jon
    Wong, Vincent W.
    El-Serag, Hashem B.
    Lee, Teng-Yu
    Wu, Ming-Shi-Ang
    Lin, Jaw-Town
    Wong, Grace L.
    Wu, Chun-Ying
    [J]. HEPATOLOGY, 2017, 66 : 1007A - 1007A
  • [9] aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
    Fan, Rong
    Papatheodoridis, George
    Sun, Jian
    Innes, Hamish
    Toyoda, Hidenori
    Xie, Qing
    Mo, Shuyuan
    Sypsa, Vana
    Guha, Indra Neil
    Kumada, Takashi
    Niu, Junqi
    Dalekos, George
    Yasuda, Satoshi
    Barnes, Eleanor
    Lian, Jianqi
    Suri, Vithika
    Idilman, Ramazan
    Barclay, Stephen T.
    Dou, Xiaoguang
    Berg, Thomas
    Hayes, Peter C.
    Flaherty, John F.
    Zhou, Yuanping
    Zhang, Zhengang
    Buti, Maria
    Hutchinson, Sharon J.
    Guo, Yabing
    Calleja, Jose Luis
    Lin, Lanjia
    Zhao, Longfeng
    Chen, Yongpeng
    Janssen, Harry L. A.
    Zhu, Chaonan
    Shi, Lei
    Tang, Xiaoping
    Gaggar, Anuj
    Wei, Lai
    Jia, Jidong
    Irving, William L.
    Johnson, Philip J.
    Lampertico, Pietro
    Hou, Jinlin
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (06) : 1368 - 1378
  • [10] Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B
    Zhang, Yuan-Qing
    Peng, Li-Jun
    Cao, Yi-Rong
    Zeng, Zhi-Ping
    Wu, Yu-Jing
    Shi, Hong
    Cheng, Shi-Yao
    Wang, Ji-Yao
    Friedman, Scott L.
    Sninsky, John J.
    Guo, Jin-Sheng
    [J]. GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (09) : 535 - 543